Daemen, A., Wolf, D.M., Korkola, J.K., Griffith, O.L., Frankum, J.R., Brough, R., Jakkula, L.R., Wang, N.J., Natrajan, R., Reis- Filho, J.S., Lord, C.J., Ashworth, A., Spellman, P.T., Gray, J.W., and van ’t Veer, L.J. (2012) Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib. Breast Cancer Res Treat. 2012 Sep;135(2):505-17 - Stand Up To Cancer

Blog

Posted September 4, 2019

Daemen, A., Wolf, D.M., Korkola, J.K., Griffith, O.L., Frankum, J.R., Brough, R., Jakkula, L.R., Wang, N.J., Natrajan, R., Reis- Filho, J.S., Lord, C.J., Ashworth, A., Spellman, P.T., Gray, J.W., and van ’t Veer, L.J. (2012) Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib. Breast Cancer Res Treat. 2012 Sep;135(2):505-17

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.